发明名称 |
Diazoxide For Use In The Treatment Or Prevention Of A Central Nervous System (CNS) Autoimmune Demyelinating Disease |
摘要 |
The invention relates to the use of diazoxide or a pharmaceutically acceptable salt thereof at low doses to treat a CNS autoimmune demyelinating disease selected from selected from multiple sclerosis (MS), clinically isolated syndrome (CIS), tumefactive (tumor-like) M S, Marburg's acute M S, Balós's concentric sclerosis, acute disseminated encephalomyelitis (ADEM), post-vaccinal encephalitis (PVE), post-infectious encephalomyelitis (PIE) and neuromyelitis optica (NMO).
|
申请公布号 |
US2013039905(A1) |
申请公布日期 |
2013.02.14 |
申请号 |
US201113520300 |
申请日期 |
2011.01.04 |
申请人 |
NEUROTEC PHARMA, S.L.;PUGLIESE MARCO;MAHY GEHENNE JOSETTE-NICOLE;RODRIGUEZ ALLUE MANUEL;ESPINOSA PARRILLA JUAN FRANCISCO;VIRGILI TRESERRES NOEMI;MANCERA AROCA PILAR;PASTEN ZAMORANO ANDREA |
发明人 |
PUGLIESE MARCO;MAHY GEHENNE JOSETTE-NICOLE;RODRIGUEZ ALLUE MANUEL;ESPINOSA PARRILLA JUAN FRANCISCO;VIRGILI TRESERRES NOEMI;MANCERA AROCA PILAR;PASTEN ZAMORANO ANDREA |
分类号 |
A61K31/5415;A61K39/395;A61P25/00 |
主分类号 |
A61K31/5415 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|